Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of Clinical Oncology

Volumn 30, Issue 18, 2012, Pages 2211-2217

  Cwynarski, Kate ^a   Van Biezen, Anja ^d   De Wreede, Liesbeth ^d   Stilgenbauer, Stephan ^f   Bunjes, Donald ^f   Metzner, Bernd ^g   Koza, Vladimir ⁱ   Mohty, Mohamad ^j   Remes, Kari ^k   Russell, Nigel ^b   Nagler, Arnon ^l   Scholten, Marijke ^d   De Witte, Theo ^e   Sureda, Anna ^c   Dreger, Peter ^h  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ULM   (Germany)

^g KLINIKUM OLDENBURG   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j HÔTEL DIEU   (France)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

^l SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; THYMOCYTE ANTIBODY;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RELAPSE; CANCER RESISTANCE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; TREATMENT OUTCOME;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYNDROME; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863995593     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.4108     Document Type: Article

References (25)

1. Robertson LE, Pugh W, O'Brien S, et al: Richter's syndrome: A report on 39 patients. J Clin Oncol 11:1985-1989, 1993 (Pubitemid 23304625)
2. Dabaja BS, O'Brien SM, Kantarjian HM, et al: Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 42:329-337, 2001 (Pubitemid 32725589)
3. Tsimberidou AM, Kantarjian HM, Cortes J, et al: Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GMCSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. Cancer 97:1711-1720, 2003 (Pubitemid 36350714)
4. Faderl S, Thomas DA, O'Brien S, et al: Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies. Blood 101:3413-3415, 2003 (Pubitemid 36857922)
5. Milojković D, Aldouri M, Pagliuca A, et al: Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy. Bone Marrow Transplant 38:461-462, 2006 (Pubitemid 44340378)
6. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
7. Schmitz N, Pfistner B, Sextro M, et al: Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet 359:2065-2071, 2002 (Pubitemid 34680969)
8. Michallet M, Dreger P, Sutton L, et al: Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: Results of European intergroup randomized trial comparing autografting versus observation. Blood 117:1516-1521, 2011
9. Michallet M, Archimbaud E, Bandini G, et al: HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia: European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med 124:311-315, 1996
10. Khouri IF, Przepiorka D, van Besien K, et al: Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 97:466-473, 1997 (Pubitemid 27224633)
11. Pavletic ZS, Arrowsmith ER, Bierman PJ, et al: Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant 25:717-722, 2000 (Pubitemid 30189511)
12. Sorror ML, Storer BE, Sandmaier BM, et al: Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. J Clin Oncol 26:4912-4920, 2008
13. Schetelig J, Thiede C, Bornhauser M, et al: Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: The Cooperative German Transplant Study Group. J Clin Oncol 21:2747-2753, 2003 (Pubitemid 46606321)
14. Dreger P, Döhner H, Ritgen M, et al: Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: Long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood 116:2438-2447, 2010
15. Schmitz N, Dreger P, Glass B, et al: Allogeneic transplantation in lymphoma: Current status. Haematologica 92:1533-1548, 2007 (Pubitemid 350144129)
16. Rezvani AR, Norasetthada L, Gooley T, et al: Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: A multicentre experience. Br J Haematol 143:395-403, 2008
17. Thomson KJ, Morris EC, Bloor A, et al: Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. J Clin Oncol 27:426-432, 2009
18. Sirvent A, Dhedin N, Michallet M, et al: Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Biol Blood Marrow Transplant 16:78-85, 2010
19. van Kampen RJ, Canals C, Schouten HC, et al: Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: An analysis of the European Group for Blood and Marrow Transplantation Registry. J Clin Oncol 29:1342-1348, 2011
20. Rodriguez J, Keating MJ, O'Brien S, et al: Allogeneic haematopoietic transplantation for Richter's syndrome. Br J Haematol 110:897-899, 2000
21. Faulkner RD, Craddock C, Byrne JL, et al: BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity and survival in 65 patients. Blood 103:428-434, 2004 (Pubitemid 38140069)
22. Morris E, Thomson K, Craddock C, et al: Outcomes after alemtuzumab-containing reducedintensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 104:3865-3871, 2004 (Pubitemid 39620131)
23. Tsimberidou AM, O'Brien S, Khouri I, et al: Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol 24:2343-2451, 2006
24. Mao Z, Quintanilla-Martinez L, Raffeld M, et al: IgVH mutational status and clonality analysis of Richter's transformation: Diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605-1614, 2007 (Pubitemid 47482476)
25. Rossi D, Cerri M, Capello D, et al: Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 142:202-215, 2008 (Pubitemid 351987315)